Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

被引:19
|
作者
Heidrich, Vitor [1 ,2 ]
Bruno, Julia S. [1 ]
Knebel, Franciele H. [1 ]
de Molla, Vinicius C. [3 ,4 ]
Miranda-Silva, Wanessa [1 ]
Asprino, Paula F. [1 ]
Tucunduva, Luciana [3 ]
Rocha, Vanderson [3 ,5 ,6 ]
Novis, Yana [3 ]
Arrais-Rodrigues, Celso [3 ,4 ]
Fregnani, Eduardo R. [3 ]
Camargo, Anamaria A. [1 ]
机构
[1] Hosp Sirio Libanes, Ctr Oncol Mol, Sao Paulo, Brazil
[2] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil
[3] Hosp Sirio Libanes, Ctr Oncol, Sao Paulo, Brazil
[4] Univ Fed Sao Paulo, Dept Oncol Clin & Expt, Sao Paulo, Brazil
[5] Univ Sao Paulo, Hosp Clin, Fac Med, Inst Canc Estado Sao Paulo ICESP, Sao Paulo, Brazil
[6] Churchill Hosp, Natl Hlth Serv Blood & Transplant, Oxford, England
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
基金
巴西圣保罗研究基金会;
关键词
oral microbiota; supragingival plaque; microbiome dysbiosis; acute GVHD; allogeneic HSCT; bone marrow transplant; GUT MICROBIOME; ORAL MICROBIOME; COLONIZATION; INHIBITION; DIVERSITY; PATHOGENS; DIAGNOSIS; BACTERIA; PROJECT; GVHD;
D O I
10.3389/fimmu.2021.692225
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acute graft-versus-host disease (aGVHD) is one of the major causes of death after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Recently, aGVHD onset was linked to intestinal microbiota (IM) dysbiosis. However, other bacterial-rich gastrointestinal sites, such as the mouth, which hosts several distinctive microbiotas, may also impact the risk of GVHD. The dental biofilm microbiota (DBM) is highly diverse and, like the IM, interacts with host cells and modulates immune homeostasis. We characterized changes in the DBM of patients during allo-HSCT and evaluated whether the DBM could be associated with the risk of aGVHD. DBM dysbiosis during allo-HSCT was marked by a gradual loss of bacterial diversity and changes in DBM genera composition, with commensal genera reductions and potentially pathogenic bacteria overgrowths. High Streptococcus and high Corynebacterium relative abundance at preconditioning were associated with a higher risk of aGVHD (67% vs. 33%; HR = 2.89, P = 0.04 and 73% vs. 37%; HR = 2.74, P = 0.04, respectively), while high Veillonella relative abundance was associated with a lower risk of aGVHD (27% vs. 73%; HR = 0.24, P < 0.01). Enterococcus faecalis bloom during allo-HSCT was observed in 17% of allo-HSCT recipients and was associated with a higher risk of aGVHD (100% vs. 40%; HR = 4.07, P < 0.001) and severe aGVHD (60% vs. 12%; HR = 6.82, P = 0.01). To the best of our knowledge, this is the first study demonstrating that DBM dysbiosis is associated with the aGVHD risk after allo-HSCT.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease
    Staffas, Anna
    da Silva, Marina Burgos
    van den Brink, Marcel R. M.
    BLOOD, 2017, 129 (08) : 927 - 933
  • [32] Helper T-Cell Differentiation in Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Jianing Fu
    Jessica Heinrichs
    Xue-Zhong Yu
    Archivum Immunologiae et Therapiae Experimentalis, 2014, 62 : 277 - 301
  • [33] Lipocalin-2 levels in acute and chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
    Hermann, Alexander
    Winkler, Andreas
    Paschen, Christopher
    Kuzmina, Zoya
    Hladik, Anastasiya
    Icme, Suephan
    Robak, Oliver
    EXPERIMENTAL HEMATOLOGY, 2019, 74 : 25 - 32
  • [34] Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation
    Gjaerde, Lars Klingen
    Sorensen, Anne Louise Tolboll
    von Stemann, Jakob Hjorth
    Fischer-Nielsen, Anne
    Hansen, Morten Bagge
    Sengelov, Henrik
    Ostrowski, Sisse Rye
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 866.e1 - 866.e9
  • [35] Early eosinophilia after hematopoietic stem cell transplantation is associated with chronic graft-versus-host disease
    Uemura, Suguru
    Kishimoto, Kenji
    Fujikawa, Tomoko
    Nakamura, Sayaka
    Kozaki, Aiko
    Saito, Atsuro
    Ishida, Toshiaki
    Mori, Takeshi
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    PEDIATRICS INTERNATIONAL, 2024, 66 (01)
  • [36] Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia
    Lee, Jung-Hee
    Lee, Je-Hwan
    Kim, Dae-Young
    Yun, Sung-Cheol
    Kim, Sung-Doo
    Choi, Yunsuk
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mi Jin
    Seol, Miee
    Lee, Kyoo-Hyung
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (02) : 172 - 181
  • [37] Altered lipid metabolism in patients with acute graft-versus-host disease after allogeneic hematopoietic cell transplantation
    Tyszka, Martyna
    Maciejewska-Markiewicz, Dominika
    Styburski, Daniel
    Bili, Jaros law
    Tomaszewska, Agnieszka
    Stachowska, Ewa
    Basak, Grzegorz W.
    LEUKEMIA RESEARCH, 2024, 137
  • [38] Helper T-Cell Differentiation in Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
    Fu, Jianing
    Heinrichs, Jessica
    Yu, Xue-Zhong
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2014, 62 (04) : 277 - 301
  • [39] Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation
    Yang, Jun
    Cheuk, Daniel Ka Leung
    Ha, Shau Yin
    Chiang, Alan Kwok Shing
    Lee, Tsz Leung
    Ho, Marco Hok Kung
    Chan, Godfrey Chi Fung
    PEDIATRIC TRANSPLANTATION, 2012, 16 (07) : 771 - 778
  • [40] Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients
    van Lier, Yannouck F.
    Davids, Mark
    Haverkate, Nienke J. E.
    de Groot, Pieter F.
    Donker, Marjolein L.
    Meijer, Ellen
    Heubel-Moenen, Floor C. J., I
    Nur, Erfan
    Zeerleder, Sacha S.
    Nieuwdorp, Max
    Blom, Bianca
    Hazenberg, Mette D.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (556)